Transgenerational effects of ERalpha36 over-expression on mammary gland development and molecular phenotype: clinical perspective for breast cancer risk and therapy. by Chamard-Jovenin, Clémence et al.
HAL Id: hal-01416469
https://hal.archives-ouvertes.fr/hal-01416469
Submitted on 26 Jan 2017
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives| 4.0
International License
Transgenerational effects of ERalpha36 over-expression
on mammary gland development and molecular
phenotype: clinical perspective for breast cancer risk
and therapy.
Clémence Chamard-Jovenin, Amand Chesnel, Emmanuel Bresso, Chloé
Morel, Charlène Thiébaut, Malika Smail-Tabbone, El-Hadi Djermoune,
Marie-Dominique Devignes, Taha Boukhobza, Hélène Dumond
To cite this version:
Clémence Chamard-Jovenin, Amand Chesnel, Emmanuel Bresso, Chloé Morel, Charlène Thiébaut,
et al.. Transgenerational effects of ERalpha36 over-expression on mammary gland development and
molecular phenotype: clinical perspective for breast cancer risk and therapy.. 21st World Congress on
Advances in Oncology and 19th International Symposium on Molecular Medicine, Oct 2016, Athens,
Greece. ￿hal-01416469￿
Transgenerational effects of ERalpha36 over-expression on mammary gland 
development and molecular phenotype: clinical perspective for breast cancer risk and 
therapy. 
Clémence Chamard-Jovenin
1
, Amand Chesnel
1
, Emmanuel Bresso
2
, Chloé Morel
1
, Charlène 
Thiébaut
1
, Malika Smail-Tabbone
2
, El-Hadi Djermoune
1
, Marie-Dominique Devignes
2
, Taha 
Boukhobza
1
 and Hélène Dumond
1
. 
1
CNRS-Université de Lorraine, UMR 7039, Centre de Recherche en Automatique de Nancy, 
BP70239, Vandœuvre-lès-Nancy, F-54506, France. 
2
LORIA, CNRS UMR 7503, INRIA, Villers les Nancy, France. 
E-mail : clemence.jovenin@univ-lorraine.fr 
 
Growing source of evidence suggests that exposure to estrogen mimicking agents is a risk 
factor for breast cancer onset and progression. Long chain alkylphenols are man-made 
compounds still present in household products, industrial and agricultural processes, leading 
to a global environmental and human contamination. These molecules are known to exert 
estrogen-like activities through binding to classical estrogen receptors. Recently, we have 
demonstrated that a realistic mixture of 4-tert-octylphenol and 4-nonylphenol can stimulate 
proliferation and modulate epigenetic status of testicular cancer germ cells through a rapid, 
Estrogen Receptor alpha 36 (ERα36)- dependent non genomic pathway (Ajj et al, 2013; doi: 
10.1371/journal.pone.0061758). In a retrospective study of breast tumor samples, we also 
validated ERα36 expression as a reliable prognostic factor for cancer progression from an 
estrogen dependent proliferative tumor toward an estrogen dispensable metastatic disease 
(Chamard-Jovenin et al, 2015; doi: 10.1186/s12918-015-0178-7). 
Since high ERα36 expression enhances expression of migration/invasion markers in breast 
tumors, we addressed the question of its involvement in response to alkylphenol exposure in 
vitro (MCF-10A mammary epithelial cell line and MCF-7 estrogen-sensitive cancer cells) and 
in vivo (C57BL mice). 
A male inherited transgenerational model of exposure to environmentally relevant doses of an 
alkylphenol mix was set up in C57BL/6J mice to determine whether and how it impacts on 
mammary gland morphogenesis. Human mammary epithelial MCF-10A cells were exposed to 
similar doses to decipher the molecular mechanisms involved by a combination of 
transcriptomic study, cell phenotype analyses, functional and signaling network modeling. 
The relevance of mouse phenotype extrapolation to human risk is discussed.  
Mouse mammary gland exposed transgenerationally to the alkylphenol mix displayed a 
neoplastic-like histology. This phenotype was correlated with the enhanced proliferation, 
migration ability and apoptosis resistance observed in vitro on human mammary epithelial 
cells and mediated by the estrogen receptor variant ERα36.  
 Since cellular phenotypes are similar in vivo and in vitro and involve the unique ERα36 
human variant, such consequences of alkylphenol exposure could be extrapolated from mouse 
model to human. Low dose alkylphenol transgenerational exposure could promote abnormal 
mammary gland development and subsequently increase the risk of breast cancer at ageing. 
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